Infantile hepatitis B in immunized children: Risk for fulminant hepatitis and long-term outcomes

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Tseng, Yu Ru ^a   Wu, Jia Feng ^a   Kong, Man Shan ^b   Hu, Fu Chang ^a   Yang, Yao Jong ^c   Yeung, Chun Yan ^d   Huang, Fu Chen ^e   Huang, I Fei ^f   Ni, Yen Hsuan ^a   Hsu, Hong Yuan ^a,g   Chang, Mei Hwei ^a   Chen, Huey Ling ^a,g  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^d MACKAY MEMORIAL HOSPITAL   (Taiwan)

^e CHANG GUNG UNIVERSITY   (Taiwan)

^f KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^g NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; LAMIVUDINE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CHILD; CHRONIC HEPATITIS; CLEARANCE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; IFHB SCORE; IMMUNIZATION; INFANT; INFANT MORTALITY; INFECTION RISK; LIVER CELL CARCINOMA; MALE; ONSET AGE; RETROSPECTIVE STUDY; SCORING SYSTEM; SEROCONVERSION; SURVIVAL; TAIWAN; ADOLESCENT; COMPLICATION; LIVER TUMOR; MOTHER; NEWBORN; PREGNANCY; PRESCHOOL CHILD; PREVENTION AND CONTROL; PROGNOSIS; RISK FACTOR; TIME; TRANSMISSION; VERTICAL TRANSMISSION;

ADOLESCENT; CARCINOMA, HEPATOCELLULAR; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS B; HUMANS; IMMUNIZATION; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LIVER NEOPLASMS; MALE; MOTHERS; PREGNANCY; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 84915817122     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111825     Document Type: Article

References (40)

1. WHO Web site. Available: http://www.who.int/mediacentre/factsheets/fs204/en/. Accessed 2014 Oct 16.
2. Lok AS, Karayiannis P, Jowett TP, Fowler MJ, Farci P, et al. (1985) Studies of HBV replication during acute hepatitis followed by recovery and acute hepatitis progressing to chronic disease. J Hepatol 1: 671-679.
3. O'Grady JG, Alexander G, Hayllar KM, Williams R (1989) Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97: 439-445.
4. Hyams KC (1995) Risks of chronicity following acute hepatitis B virus infection: a review. Clin Liver Dis 20: 992-1000.
5. Chang MH (2010) Hepatitis B vaccination: disease and cancer prevention-a Taiwanese experience. Clin Liver Dis 14: 521-530.
6. Fortuin M, Chotard J, Jack AD, Maine NP, Mendy M, et al. (1993) Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation. Lancet 341: 1129-1131.
7. McMahon BJ, Bulkow LR, Singleton RJ, Williams J, Snowball M, et al. (2011) Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program. Hepatology 54: 801-807.
8. Chen DS, Hsu NH, Sung JL, Hsu TC, Hsu ST, et al. (1987) A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 257: 2597-2603.
9. Chen HL, Chang MH, Ni YH, Hsu HY, Lee PI, et al. (1996) Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan. JAMA 276: 906-908.
10. Ni YH, Huang LM, Chang MH, Yen CJ, Lu CY, et al. (2007) Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies. Gastroenterology 132: 1287-1293.
11. Su WJ, Liu CC, Liu DP, Chen SF, Huang JJ, et al. (2012) Effect of age on the incidence of acute hepatitis B after 25 years of a universal newborn hepatitis B immunization program in Taiwan. J Infect Dis 205: 757-762.
12. Wasley A, Miller JT, Finelli L, (CDC) CfDCaP (2007) Surveillance for acute viral hepatitis-United States, 2005. MMWR Surveill Summ 56: 1-24.
13. Chen HL, Lin LH, Hu FC, Lee JT, Lin WT, et al. (2012) Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology 142: 773-781.e772.
14. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, et al. (1997) Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 336: 1855-1859.
15. Chang MH, You SL, Chen CJ, Liu CJ, Lee CM, et al. (2009) Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year followup study. J Natl Cancer Inst 101: 1348-1355.
16. Beasley RP, Hwang LY, Lin CC, Leu ML, Stevens CE, et al. (1982) Incidence of hepatitis B virus infections in preschool children in Taiwan. J Infect Dis 146: 198-204.
17. Dupuy JM, Frommel D, Alagille D (1975) Severe viral hepatitis type B in infancy. Lancet 305: 191-194.
18. Chang MH, Lee CY, Chen DS, Hsu HC, Lai MY (1987) Fulminant hepatitis in children in Taiwan: the important role of hepatitis B virus. J Pediatr 111: 34-39.
19. Chen HL, Chang CJ, Kong MS, Huang FC, Lee HC, et al. (2004) Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination. Hepatology 39: 58-63.
20. Friedt M, Gerner P, Lausch E, Trübel H, Zabel B, et al. (1999) Mutations in the basic core promotor and the precore region of hepatitis B virus and their selection in children with fulminant and chronic hepatitis B. Hepatology 29: 1252-1258.
21. Cacciola I, Cerenzia G, Pollicino T, Squadrito G, Castellaneta S, et al. (2002) Genomic heterogeneity of hepatitis B virus (HBV) and outcome of perinatal HBV infection. J Hepatol 36: 426-432.
22. Rosh JR, Schwersenz AH, Groisman G, Benkov KJ, LeLeiko NS (1994) Fatal fulminant hepatitis B in an infant despite appropriate prophylaxis. Arch Pediatr Adolesc Med 148: 1349-1351.
23. Squires RH Jr, Shneider BL, Bucuvalas J, Alonso E, Sokol RJ, et al. (2006) Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr 148: 652-658.
24. Pollicino T, Zanetti AR, Cacciola I, Petit MA, Smedile A, et al. (1997) Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. Hepatology 26: 495-499.
25. Mu SC, Lin YM, Jow GM, Chen BF (2009) Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan. J Hepatol 50: 264-272.
26. Chen SC, Toy M, Yeh JM, Wang JD, Resch S (2013) Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobin treatment. Pediatrics 131: e1135-1143.
27. Bortolotti F, Bertaggia A, Crivellaro C, Armigliato M, Alberti A, et al. (1986) Chronic evolution of acute hepatitis type B: prevalence and predictive markers. Infection 14: 64-67.
28. Kellerman SE, Hanson DL, McNaghten A, Fleming PL (2003) Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. J Infect Dis 188: 571-577.
29. Beasley RP (2009) Rocks along the road to the control of HBV and HCC. Ann Epidemiol 19: 231-234.
30. Wirth S, Gerner P, Oettinger R, Friedt M, Truebel H (2002) Persistent hepatitis B virus replication after survival of fulminant hepatitis and clearance of HBsAg. J Pediatr Gastroenterol Nutr 34: 77-80.
31. Ni YH, Chang MH, Chen PJ, Tsai KS, Hsu HY, et al. (2007) Viremia profiles in children with chronic hepatitis B virus infection and spontaneous e antigen seroconversion. Gastroenterology 132: 2340-2345.
32. Liaw YF, Lau GK, Kao JH, Gane E (2010) Hepatitis B e antigen seroconversion: a critical event in chronic hepatitis B virus infection. Dig Dis Sci 55: 2727-2734.
33. Chang MH, Hsu HY, Hsu HC, Ni YH, Chen JS, et al. (1995) The significance of spontaneous hepatitis B e antigen seroconversion in childhood: with special emphasis on the clearance of hepatitis B e antigen before 3 years of age. Hepatology 22: 1387-1392.
34. Wen WH, Chang MH, Hsu HY, Ni YH, Chen HL (2004) The development of hepatocellular carcinoma among prospectively followed children with chronic hepatitis B virus infection. J Pediatr 144: 397-399.
35. Chang MH, Chen TH, Hsu HM, Wu TC, Kong MS, et al. (2005) Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems. Clin Cancer Res 11: 7953-7957.
36. Haber BA, Block JM, Jonas MM, Karpen SJ, London WT, et al. (2009) Recommendations for screening, monitoring, and referral of pediatric chronic hepatitis B. Pediatrics 124: e1007-e1013.
37. Hsu HY, Chang MH, Hsieh KH, Lee CY, Lin HH, et al. (1992) Cellular immune response to HBcAg in mother-to-infant transmission of hepatitis B virus. Hepatology 15: 770-776.
38. Omata M, Ehata T, Yokosuka O, Hosoda K, Ohto M (1991) Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 324: 1699-1704.
39. Hsu HY, Chang MH, Lee CY, Hsieh KH, Ni YH, et al. (1995) Precore mutant of hepatitis B virus in childhood fulminant hepatitis B: an infrequent association. J Infect Dis 171: 776-781.
40. Liang TJ, Hasegawa K, Munoz SJ, Shapiro CN, Yoffe B, et al. (1994) Hepatitis B virus precore mutation and fulminant hepatitis in the United States. A polymerase chain reaction-based assay for the detection of specific mutation. J Clin Invest 93: 550-555.